Press Releases

All Releases
View Summary MannKind Announces Closing of Global Licensing Agreement With Sanofi
09/24/14
PDF 8.7 KB Add to Briefcase
View Summary MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference
09/02/14
PDF 8.2 KB Add to Briefcase
View Summary Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin
08/11/14
PDF 18.0 KB Add to Briefcase
View Summary MannKind Corporation Reports 2014 Second Quarter Financial Results
08/11/14
PDF 18.0 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014
08/05/14
PDF 8.6 KB Add to Briefcase
View Summary MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes
06/27/14
PDF 14.9 KB Add to Briefcase
View Summary MannKind to Present at Upcoming Conferences
05/27/14
PDF 8.6 KB Add to Briefcase
View Summary MannKind Corporation Reports 2014 First Quarter Financial Results
05/12/14
PDF 15.8 KB Add to Briefcase
View Summary MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference
05/07/14
PDF 8.3 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014
05/05/14
PDF 8.7 KB Add to Briefcase
View Summary MannKind Updates Status of New Drug Application for AFREZZA(R)
04/07/14
PDF 8.9 KB Add to Briefcase
View Summary FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes
04/01/14
PDF 10.4 KB Add to Briefcase
View Summary MannKind Corporation to Present at Upcoming Conferences
02/19/14
PDF 8.7 KB Add to Briefcase
View Summary MannKind Corporation Reports 2013 Fourth Quarter and Full Year Financial Results
02/18/14
PDF 17.7 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2013 Fourth Quarter and Full Year Financial Results Conference Call on February 18, 2014
02/04/14
PDF 8.7 KB Add to Briefcase
View Summary MannKind Announces Tentative Date of FDA Advisory Committee Review of AFREZZA
01/10/14
PDF 8.0 KB Add to Briefcase
View Summary MannKind Corporation to Present at the J.P. Morgan 2014 Healthcare Conference
01/08/14
PDF 8.3 KB Add to Briefcase
View Summary MannKind Corporation to Present at The Piper Jaffray 25th Annual Healthcare Conference
11/27/13
PDF 8.7 KB Add to Briefcase
View Summary MannKind Corporation to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
11/07/13
PDF 8.7 KB Add to Briefcase
View Summary MannKind Corporation Reports 2013 Third Quarter Financial Results
11/04/13
PDF 13.5 KB Add to Briefcase
Showing 81-100 of 297 Page: 1 2 3 4 5 6 7 8 9 ... 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price: 1.56

Change: 0.05 (3.311%)

Volume: 1,409,284

Data as of
06/27/2017 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

Locations

Learn more about MannKind's offices in the United States

Learn More